BDBM434010 US10562887, Example 129::l-(4-(1H-pyrazol-4- yl)phenyl)-4-(2,5- difluorobenzyl)-3- (hydroxymethyl)-1H- 1,2,4-triazol-5(4H)- one

SMILES OCc1nn(-c2ccc(cc2)-c2cn[nH]c2)c(=O)n1Cc1cc(F)ccc1F

InChI Key InChIKey=QLVLWBHYEQXILM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 434010   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM434010(l-(4-(1H-pyrazol-4- yl)phenyl)-4-(2,5- difluoroben...)
Affinity DataIC50: 27.5nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL, assay containing 20 mM HEPES, pH 7.5, 2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent